Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MYM Nutraceuticals Inc MYMMF

Healthcare Drug Manufacturers - Major
MYM Nutraceuticals Inc is a Canada based company engaged in the business of acquiring and developing natural remedies. The company is focused on the medical marijuana business by producing cannabis growing facilities and products.


GREY:MYMMF - Post by User

MYM Nutraceuticals Inc > So Sad
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(9)
•••
Comment by biketrader98on Apr 15, 2021 12:00pm
93 Views
Post# 33000858

RE:RE:RE:So Sad

RE:RE:RE:So SadWhat is it that we need to know?  I thought Trichome had financed MYM and kept them propped up when nobody else would.  Other than being under market at the time of the announcement, it would appear on the surface to be a benefit to join the IM bandwagon. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities